26-01-2020 18:00 via medpagetoday.com

Escalating Stelara Dose Possible in Unresponsive Crohn's

]]>(MedPage Today) -- AUSTIN--Dose escalation of ustekinumab (Stelara) should be considered for patients with Crohn's disease and manifestations of the condition, a researcher said here.Among 38 adults with Crohn's disease, 60% improved with...
Read more »